MARC details
000 -LEADER |
fixed length control field |
03951cam a2200421Mi 4500 |
001 - CONTROL NUMBER |
control field |
ocn953657042 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20240726104734.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
160716s2015 xx ob 001 0 eng d |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
EBLCP |
Language of cataloging |
eng |
Description conventions |
pn |
-- |
rda |
Transcribing agency |
EBLCP |
Modifying agency |
OCLCQ |
-- |
CCO |
-- |
OCLCO |
-- |
COCUF |
-- |
LOA |
-- |
K6U |
-- |
OCLCF |
-- |
STF |
-- |
PIFAG |
-- |
FVL |
-- |
MERUC |
-- |
OCLCQ |
-- |
ZCU |
-- |
U3W |
-- |
WRM |
-- |
ICG |
-- |
OCLCQ |
-- |
VT2 |
-- |
OCLCQ |
-- |
TKN |
-- |
DKC |
-- |
OCLCQ |
-- |
UKAHL |
-- |
OCLCQ |
-- |
NT |
066 ## - CHARACTER SETS PRESENT |
Alternate G0 or G1 character set |
Zsym |
-- |
(S |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781681081403 |
Qualifying information |
|
050 04 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
QR177 |
Item number |
.C435 2015 |
049 ## - LOCAL HOLDINGS (OCLC) |
Holding library |
MAIN |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Manuela, Oliveira. |
Relator term |
Author |
245 10 - TITLE STATEMENT |
Title |
The challenges of antibiotic resistance in the development of new therapeutics. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
Sharjah : |
Name of publisher, distributor, etc. |
Bentham Science Publishers, |
Date of publication, distribution, etc. |
(c)2015. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 online resource (279 pages) |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
computer |
Media type code |
c |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
online resource |
Carrier type code |
cr |
Source |
rdacarrier |
347 ## - DIGITAL FILE CHARACTERISTICS |
File type |
data file |
Source |
rda |
490 1# - SERIES STATEMENT |
Series statement |
Frontiers in Antimicrobial Agents ; |
Volume # |
v. 1 |
505 00 - FORMATTED CONTENTS NOTE |
Linkage |
880-01 |
Formatted contents note |
FOREWORD ; PREFACE ; List of Contributors ; Introduction ; INTRODUCTION; CONFLICT OF INTEREST; ACKNOWLEDGEMENTS; REFERENCES; Bacteriophages as Antibacterial Agents: Why are We Facing an Antibiotic Crisis and How Could Bacteriophages be of Help? ; 1. INTRODUCTION; 2. WHY ARE WE FACING AN ANTIBIOTIC (AB) CRISIS? ; 3. HOW TO RESOLVE THIS ANTIBIOTIC CRISIS? ; 4. BACTERIOPHAGES OR IN SHORT 'PHAGES'; 5. BACTERIOPHAGE THERAPY OR PHAGE THERAPY; 6. EXPERIMENTAL PHAGE THERAPY; 7. SAFETY ISSUES; 8. IN FACT WE LIVE IN AN "OCEAN" OF BACTERIOPHAGES; 9. SAFETY REQUIREMENTS FOR PHAGE THERAPY. |
505 00 - FORMATTED CONTENTS NOTE |
Formatted contents note |
10. THE POTENTIAL ADVANTAGES OF PHAGE THERAPY VERSUS ANTIBIOTICS11. PHAGE THERAPY IN PUBLIC HEALTH; 12. WHY PHAGE THERAPY IS NOT YET IMPLEMENTED?; CONCLUSIONS AND PERSPECTIVES; CONFLICT OF INTEREST; ACKNOWLEDGEMENTS; REFERENCES; Antimicrobial Peptides ; INTRODUCTION; 1. WHAT ARE ANTIMICROBIAL PEPTIDES (AMPS); 1.1. Mode of Action; 1.2. Immune System; 1.3. Resistance; 2. CHRONOLOGY OF AMPS DISCOVERY -- |
Title |
A BRIEF HISTORY; 2.1. Classification of AMPs; 2.1.1. Biological Source; 2.1.2. Biological Functions; 2.1.3. Biosynthesis; 2.1.4. Molecular Properties; 2.1.5. Molecular Targets. |
505 00 - FORMATTED CONTENTS NOTE |
Formatted contents note |
2.1.6. Three-Dimensional (3D) Structure2.2. Currently Active AMPs Databases; 3. THERAPEUTIC APPLICATIONS OF AMPS; 3.1. Anticancer AMPs; 3.2. Antiviral AMPs; 3.3. Anti-parasitic AMPs; 3.4. New Generation of AMPs; CONCLUDING REMARKS; CONFLICT OF INTEREST; ACKNOWLEDGEMENTS; REFERENCES; Probiotics: Ways of Action and Beneficial Effects ; 1. INTRODUCTION; 2. SELECTION OF PROBIOTICS; 3. COMMERCIALLY IMPORTANT PROBIOTICS; 4. MECHANISMS OF ACTION OF PROBIOTICS; 4.1. Immunomodulation; 4.2. Direct Effects on Other Microorganisms; 5. BENEFICIAL HEALTH EFFECTS OF PROBIOTICS. |
505 00 - FORMATTED CONTENTS NOTE |
Formatted contents note |
5.1. Alleviation of Lactose Intolerance5.2. Effect on Helicobacter Pylori Eradication ; 5.3. Anti-carcinogenic Effect; 5.4. Cholesterol-lowering Effects; 5.5. Allergy and Atopic Dermatitis; 5.6. Inflammatory Diseases and Bowel Syndromes ; CONCLUSION; CONFLICT OF INTEREST; ACKNOWLEDGEMENTS; REFERENCES; Immunotherapy ; 1. BACTERIAL INFECTIVITY, IMMUNE RESPONSE AND MULTIRESISTANT INFECTIONS : NEW PERSPECTIVES; 1.1. Introduction; 1.2. Host Resistance; 1.3. Bacterial Strategies for Evading, Surviving Host Defense Systems and Create Infection; 2. IMMUNOTHERAPY; 2.1. Introduction. |
500 ## - GENERAL NOTE |
General note |
2.10.2. Propionibacterium Acnes. |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
|
530 ## - COPYRIGHT INFORMATION: |
COPYRIGHT INFORMATION |
COPYRIGHT NOT covered - Click this link to request copyright permission: |
Uniform Resource Identifier |
<a href="b">b</a> |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drug resistance in microorganisms. |
655 #1 - INDEX TERM--GENRE/FORM |
Genre/form data or focus term |
Electronic Books. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Serrano, Isa D. |
856 40 - ELECTRONIC LOCATION AND ACCESS |
-- |
Click to access digital title | log in using your CIU ID number and my.ciu.edu password. |
Uniform Resource Identifier |
<a href="httpss://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=1108996&site=eds-live&custid=s3260518">httpss://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=1108996&site=eds-live&custid=s3260518</a> |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
Online Book (LOGIN USING YOUR MY CIU LOGIN AND PASSWORD) |
DONATED BY: |
|
VENDOR |
EBSCO |
Classification part |
QR |
PUBLICATION YEAR |
2015 |
LOCATION |
ONLINE |
REQUESTED BY: |
|
-- |
|
-- |
NFIC |
Source of classification or shelving scheme |
|
994 ## - |
-- |
92 |
-- |
NT |
902 ## - LOCAL DATA ELEMENT B, LDB (RLIN) |
a |
1 |
b |
Cynthia Snell |
c |
1 |
d |
Cynthia Snell |